Autologous HIV-1–specific cytotoxic T lymphocyte (CTL) infusion
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Autologous HIV-1–specific cytotoxic T lymphocyte (CTL) infusion, covering 2018-04-26 to 2018-04-26. Get the full timeline:
Most recent: Clinical Trial Update: Early cART and cART in Combination With Autologous HIV-1 Specific Cytotoxic T Lymphocyte (CTL) Infusion in The Treatment of Acute HIV-1 Infected Adults [Phase 3]